Today, ISTH TV highlights several big topics at the ISTH 2017 Congress in Berlin, Germany. The first episode is entitled “Managing DOAC-Related Bleeding: Putting Idarucizumab and Andexanet Data Into Practice”. Host Thomas Baldrick talks with Charles Pollack, M.D., lead author of the RE-VERSE AD study with idarucizumab for the reversal of dabigatran anticoagulation. Next, Beverley Hunt, M.D. joins her colleagues Saskia Middeldorp, M.D. and Alexander (Ander) T. Cohen, M.B.B.S., M.Sc., M.D., F.R.A.C.P. to discuss the issues associated with DOAC-related bleeding and its management, including new data from the ANNEXA study with andexanet alfa presented at ISTH this week. As you leave the Congress, stay tuned to ISTH TV and ISTH Congress Daily for more information from the ISTH 2017 meeting in Berlin.